BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 10048151)

  • 21. Cell specificity for the pulmonary metabolism of tobacco-specific nitrosamines in the Fischer rat.
    Belinsky SA; White CM; Trushin N; Hecht SS
    Carcinogenesis; 1989 Dec; 10(12):2269-74. PubMed ID: 2591016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acrolein Increases the Pulmonary Tumorigenic Activity of the Tobacco-Specific Nitrosamine 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Peterson LA; Seabloom D; Smith WE; Vevang KR; Seelig DM; Zhang L; Wiedmann TS
    Chem Res Toxicol; 2022 Oct; 35(10):1831-1839. PubMed ID: 36149460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA and hemoglobin alkylation by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its major metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats.
    Hecht SS; Trushin N
    Carcinogenesis; 1988 Sep; 9(9):1665-8. PubMed ID: 3409470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thirdhand cigarette smoke in an experimental chamber: evidence of surface deposition of nicotine, nitrosamines and polycyclic aromatic hydrocarbons and de novo formation of NNK.
    Schick SF; Farraro KF; Perrino C; Sleiman M; van de Vossenberg G; Trinh MP; Hammond SK; Jenkins BM; Balmes J
    Tob Control; 2014 Mar; 23(2):152-9. PubMed ID: 23716171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K-ras gene sequence effects on the formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-DNA adducts.
    Ziegel R; Shallop A; Jones R; Tretyakova N
    Chem Res Toxicol; 2003 Apr; 16(4):541-50. PubMed ID: 12703972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 11Beta-hydroxysteroid dehydrogenase responsible for carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes.
    Maser E
    Cancer Res; 1998 Jul; 58(14):2996-3003. PubMed ID: 9679962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model.
    Megaraj V; Zhou X; Xie F; Liu Z; Yang W; Ding X
    Carcinogenesis; 2014 Jan; 35(1):131-7. PubMed ID: 23917075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of tobacco-specific nitrosamine-induced lung tumorigenesis in A/J mice by green tea and its major polyphenol as antioxidants.
    Xu Y; Ho CT; Amin SG; Han C; Chung FL
    Cancer Res; 1992 Jul; 52(14):3875-9. PubMed ID: 1617663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexposure to Inhaled Aldehydes or Carbon Dioxide Enhances the Carcinogenic Properties of the Tobacco-Specific Nitrosamine 4-Methylnitrosamino-1-(3-pyridyl)-1-butanone in the A/J Mouse Lung.
    Peterson LA; Oram MK; Flavin M; Seabloom D; Smith WE; O'Sullivan MG; Vevang KR; Upadhyaya P; Stornetta A; Floeder AC; Ho YY; Zhang L; Hecht SS; Balbo S; Wiedmann TS
    Chem Res Toxicol; 2021 Mar; 34(3):723-732. PubMed ID: 33629582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of human cytochrome P450 2E1 by nicotine, cotinine, and aqueous cigarette tar extract in vitro.
    Van Vleet TR; Bombick DW; Coulombe RA
    Toxicol Sci; 2001 Dec; 64(2):185-91. PubMed ID: 11719700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Clara cells and type II cells in the development of pulmonary tumors in rats and mice following exposure to a tobacco-specific nitrosamine.
    Belinsky SA; Devereux TR; White CM; Foley JF; Maronpot RR; Anderson MW
    Exp Lung Res; 1991; 17(2):263-78. PubMed ID: 2050030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methyl DNA Phosphate Adduct Formation in Rats Treated Chronically with 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and Enantiomers of Its Metabolite 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol.
    Ma B; Zarth AT; Carlson ES; Villalta PW; Upadhyaya P; Stepanov I; Hecht SS
    Chem Res Toxicol; 2018 Jan; 31(1):48-57. PubMed ID: 29131934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4-(Hydroxymethylnitrosamino)-1-(3-pyridyl)-1-butanone glucuronide has the potential to form 2'-deoxyguanosine and N-acetylcysteine adducts.
    Nishiyama T; Hayashi N; Yanagita H; Ohnuma T; Ogura K; Hiratsuka A
    J Toxicol Sci; 2019; 44(10):693-699. PubMed ID: 31588060
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancements of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism and carcinogenic risk via NNK/arsenic interaction.
    Lee HL; Chang LW; Wu JP; Ueng YF; Tsai MH; Hsieh DP; Lin P
    Toxicol Appl Pharmacol; 2008 Feb; 227(1):108-14. PubMed ID: 17976671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyridyloxobutyl DNA adducts inhibit the repair of O6-methylguanine.
    Peterson LA; Liu XK; Hecht SS
    Cancer Res; 1993 Jun; 53(12):2780-5. PubMed ID: 8504419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Two types of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone hemoglobin adducts, from metabolites which migrate into or are formed in red blood cells.
    Murphy SE; Coletta KA
    Cancer Res; 1993 Feb; 53(4):777-83. PubMed ID: 8428358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone bioactivation in mouse by dietary phenethyl isothiocyanate.
    Smith TJ; Guo Z; Li C; Ning SM; Thomas PE; Yang CS
    Cancer Res; 1993 Jul; 53(14):3276-82. PubMed ID: 8324738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK.
    Murphy SE; Nunes MG; Hatala MA
    Chem Biol Interact; 1997 Mar; 103(3):153-66. PubMed ID: 9134006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of methyl DNA adducts and metabolites in BEAS-2B cells induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Wang H; Li X; Zhao G; Xu L; Wang S; Nie M; Hua C; Shang P; Pan L; Zhao J; Qiao L; Liu K; Hu K; Su J; Cai J; Xie F
    Toxicol Mech Methods; 2019 Sep; 29(7):499-510. PubMed ID: 31050318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation--a mammalian cell-based mutagenesis approach.
    Chiang HC; Wang CY; Lee HL; Tsou TC
    Toxicol Appl Pharmacol; 2011 Jun; 253(2):145-52. PubMed ID: 21473878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.